Cutaneous adverse effects of methylene blue in an animal skin-flap model

References

• de Bree R, Nieweg OE. The history of sentinel node biopsy in head and neck cancer: from visualization of lymphatic vessels to sentinel nodes. Oral Oncol. 2015;51:819–823.
   PubMed Web of Science ®Google Scholar
• Newman EA, Newman LA. Lymphatic mapping techniques and sentinel lymph node biopsy in breast cancer. Surg Clin North Am. 2007;87:353–364.
   PubMed Web of Science ®Google Scholar
• Somasundaram SK, Chicken DW, Keshtgar MR. Detection of the sentinel lymph node in breast cancer. Br Med Bull. 2007;84:117–131.
   PubMed Web of Science ®Google Scholar
• Tausch C, Baege A, Rageth C. Mapping lymph nodes in cancer management – role of (99m)Tc-tilmanocept injection. Onco Targets Ther. 2014;7:1151–1158.
   PubMed Web of Science ®Google Scholar
• Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127:392–399.
   PubMed Web of Science ®Google Scholar
• Krag DN, Weaver DL, Alex JC, et al. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol. 1993;6:335–339.
   Web of Science ®Google Scholar
• Cody HS. III Clinical aspects of sentinel node biopsy. Breast Cancer Res. 2001;3:104–108.
   PubMed Web of Science ®Google Scholar
• Lyman GH, Giuliano AE, Somerfield MR, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol. 2005;20:7703–7720.
   Web of Science ®Google Scholar
• Giuliano AE, Kirgan DM, Guenther JM, et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 1994;220:391–398.
   PubMed Web of Science ®Google Scholar
• Kuerer HM, Wayne JD, Ross MI. Anaphylaxis during breast cancer lymphatic mapping. Surgery. 2001;129:119–120.
   PubMed Web of Science ®Google Scholar
• Lyew MA, Gamblin TC, Ayoub M. Systemic anaphylaxis associated with intramammary isosulfan blue injection used for sentinel node detection under general anesthesia. Anesthesiology. 2000;93:1145–1146.
   PubMed Web of Science ®Google Scholar
• Montgomery LL, Thorne AC, Van Zee KJ, et al. Isosulfan blue dye reactions during sentinel lymph node mapping for breast cancer. Anesth Analg. 2002;95:385–388.
   PubMed Web of Science ®Google Scholar
• Salhab M, Al Sarakbi W, Mokbel K. Skin and fat necrosis of the breast following methylene blue dye injection for sentinel node biopsy in a patient with breast cancer. Int Semin Surg Oncol. 2005;2:26.
   PubMedGoogle Scholar
• Blessing WD, Stolier AJ, Teng SC, et al. A comparison of methylene blue and lymphazurin in breast cancer sentinel node mapping. Am J Surg. 2002;184:341–345.
   PubMed Web of Science ®Google Scholar
• Thevarajah S, Huston TL, Simmons RM. A comparison of the adverse reactions associated with isosulfan blue versus methylene blue dye in sentinel lymph node biopsy for breast cancer. Am J Surg. 2005;189:236–239.
   PubMed Web of Science ®Google Scholar
• Cimmino VM, Brown AC, Szocik JF, et al. Allergic reactions to isosulfan blue during sentinel node biopsy-a common event. Surgery. 2001;130:439–442.
   PubMed Web of Science ®Google Scholar
• Derossis AM, Fey J, Yeung H, et al. A trend analysis of the relative value of blue dye and isotope localization in 2,000 consecutive cases of sentinel node biopsy for breast cancer. J Am Coll Surg. 2001;193:473–478.
   PubMed Web of Science ®Google Scholar
• van der Ent FW, Kengen RA, van der Pol HA, et al. Sentinel node biopsy in 70 unselected patients with breast cancer: increased feasibility by using 10 mCi radiocolloid in combination with a blue dye tracer. Eur J Surg Oncol. 1999;25:24–29.
   PubMed Web of Science ®Google Scholar
• Simmons RM, Rosenbaum Smith SM, Osborne MP. Methylene blue dye as an alternative to isosulfan blue dye for sentinel lymph node localization. Breast J. 2001;7:181–183.
   PubMedGoogle Scholar
• Varghese P, Mostafa A, Abdel-Rahman AT, et al. Methylene blue dye versus combined dye-radioactive tracer technique for sentinel lymph node localisation in early breast cancer. Eur J Surg Oncol. 2007;33:147–152.
   PubMed Web of Science ®Google Scholar
• Stradling B, Aranha G, Gabram S. Adverse skin lesions after methylene blue injections for sentinel lymph node localization. Am J Surg. 2002;184:350–352.
   PubMed Web of Science ®Google Scholar
• Zakaria S, Hoskin TL, Degnim AC. Safety and technical success of methylene blue dye for lymphatic mapping in breast cancer. Am J Surg. 2008;196:228–233.
   PubMed Web of Science ®Google Scholar
• Reyes F, Noelck M, Valentino C, et al. Complications of methylene blue dye in breast surgery: case reports and review of the literature. J Cancer. 2010;2:20–25.
   PubMed Web of Science ®Google Scholar
• Lee JH, Chang CH, Park CH, et al. Methylene blue dye-induced skin necrosis in immediate breast reconstruction: evaluation and management. Arch Plast Surg. 2014;41:258–263.
   PubMedGoogle Scholar
• Dumbarton TC, Gorman SK, Minor S, et al. Local cutaneous necrosis secondary to a prolonged peripheral infusion of methylene blue in vasodilatory shock. Ann Pharmacother. 2012;46:e6.
   PubMedGoogle Scholar
• Johnson PC, Sheppeck R. The dark side of methylene blue. Plast Reconstr Surg. 1989;83:1076–1077.
   PubMed Web of Science ®Google Scholar